Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 280.6 SEK 1.08% Market Closed
Market Cap: 8.8B SEK

Wall Street
Price Targets

XVIVO Price Targets Summary
Xvivo Perfusion AB

Wall Street analysts forecast XVIVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XVIVO is 488.99 SEK with a low forecast of 328.25 SEK and a high forecast of 595.35 SEK.

Lowest
Price Target
328.25 SEK
17% Upside
Average
Price Target
488.99 SEK
74% Upside
Highest
Price Target
595.35 SEK
112% Upside
Xvivo Perfusion AB Competitors:
Price Targets
GENT
Gentian Diagnostics ASA
52% Upside
RMTI
Rockwell Medical Inc
300% Upside
ANN
Ansell Ltd
30% Upside
STAA
STAAR Surgical Co
37% Upside
YPSN
Ypsomed Holding AG
42% Upside
137310
SD Biosensor Inc
26% Upside
099430
BioPlus Co Ltd
24% Upside
TOPGLOV
Top Glove Corporation Bhd
16% Upside

Revenue
Forecast

Revenue Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 25%. The projected CAGR for the next 3 years is 34%.

25%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is 35%. The projected CAGR for the next 3 years is 71%.

35%
Past Growth
71%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Net Income
Forecast

Net Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 81%. The projected CAGR for the next 3 years is 27%.

81%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XVIVO's stock price target?
Price Target
488.99 SEK

According to Wall Street analysts, the average 1-year price target for XVIVO is 488.99 SEK with a low forecast of 328.25 SEK and a high forecast of 595.35 SEK.

What is Xvivo Perfusion AB's Revenue forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 25%. The projected CAGR for the next 3 years is 34%.

What is Xvivo Perfusion AB's Operating Income forecast?
Projected CAGR
71%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is 35%. The projected CAGR for the next 3 years is 71%.

What is Xvivo Perfusion AB's Net Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 81%. The projected CAGR for the next 3 years is 27%.

Back to Top